Ulrich Herrlinger

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Radiation Induced

Top Venues

Nature communications

Molecular oncology

Nature reviews. Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Matthias Schneider, Anna-Laura Potthoff, Georg Karpel-Massler, Patrick Schuss, Markus D Siegelin, Klaus-Michael Debatin, Hugues Duffau, Hartmut Vatter, Ulrich Herrlinger, Mike-Andrew Westhoff
The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours. Molecular oncology (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Johannes Weller, Anna-Laura Potthoff, Thomas Zeyen, Christina Schaub, Cathrina Duffy, Matthias Schneider, Ulrich Herrlinger
Current status of precision oncology in adult glioblastoma. Molecular oncology (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Johannes Weller, Anna-Laura Potthoff, Thomas Zeyen, Christina Schaub, Cathrina Duffy, Matthias Schneider, Ulrich Herrlinger
Current status of precision oncology in adult glioblastoma. Molecular oncology (2024)
Frank A Giordano, Julian Philipp Layer, Sonia Leonardelli, Lea L Friker, Roberta Turiello, Dillon Corvino, Thomas Zeyen, Christina Schaub, Wolf Müller, Elena Sperk, Leonard Christopher Schmeel, Katharina Sahm, Christoph Oster, Sied Kebir, Peter Hambsch, Torsten Pietsch, Sotirios Bisdas, Michael Platten, Martin Glas, Clemens Seidel, Ulrich Herrlinger, Michael Hudecek
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial. Nature communications 15 (1) (2024)
Varun Venkataramani, Matthias Schneider, Frank Anton Giordano, Thomas Kuner, Wolfgang Wick, Ulrich Herrlinger, Frank Winkler
Disconnecting multicellular networks in brain tumours. Nature reviews. Cancer 22 (8) (2022)